Maruti Suzuki boosts Baleno production to cut down waiting, delights customers
With a core focus to enhance customer experience, Maruti Suzuki India has increased production of its blockbuster model Baleno. This will delight customers by reducing the waiting period for Baleno. Launched in October 2015, Baleno is one of the top selling models for Maruti Suzuki.
The premium hatchback has been featuring among India’s top five best selling cars since March 2017. Maruti Suzuki has sold over 450,000 units of Baleno cumulatively, since its launch.
R.S. Kalsi, Senior Executive Director (Marketing and Sales), Maruti Suzuki said, “The high demand for Baleno since its launch is a testimony of our best in class technology, design and customer experience. The availability of Baleno got a boost with the Suzuki Motor Gujarat plant operational at its full capacity of 2.5 lakh units annually. We are confident that with increased production of Baleno we will be able to enhance the car ownership experience of our NEXA customers. With improved availability the average monthly sales of Baleno has touched around 18,000 units in the past 8 months, as compared to an average of around 14,000 units in the Jan’17-Aug’17 periods.”
A symbol of the Make-in-India mission, Baleno is exclusively manufactured in India. It is the first car to be exported from India to Japan. And, besides domestic market the premium hatchback received overwhelming response in global markets such as Australia, Europe, Latin America and East Asia.
Baleno with its bold design, best in segment safety and convenience features is one of the most awarded premium hatchback of recent times.
Maruti Suzuki India Ltd is currently trading up 2.06% at Rs8,677.35 from its previous closing of Rs8,502.10 on the BSE.
The scrip opened at Rs8,581 and has touched a high and low of Rs8,693.40 and Rs8,581 respectively.
Financial Advisory which means a lot to a Financial trader and we can do a best with your investments with all mandatory work skills subscribe us now and get two days Free Trial >> Bonaz Capital